WHO ICTRP trial
Application of two-dimensional central and peripheral markers in precision…
ChiCTR2000036644 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000036644 |
|---|---|
| Public title | Application of two-dimensional central and peripheral markers in precision diagnosis and prediction of Alzheimer's disease |
| Scientific title | Application of two-dimensional central and peripheral markers in precision diagnosis and prediction of Alzheimer's disease |
| Primary sponsor | Renji Hospital, School of Medicine, Shanghai Jiaotong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | Alzheimer's disease |
| Interventions | Gold Standard:Aß amyloid;Index test:plasma p-Tau217, plasma p-Tau181 |
| Registration date | Aug 24, 2020 |
| Target size | Target condition:75;Difficult condition:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: